| Net Cash Provided by (Used in) Operating Activities |
264K |
USD |
|
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
0 |
USD |
-100% |
Q2 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
75M |
shares |
0% |
Q2 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
25M |
shares |
0% |
Q2 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
1.05M |
USD |
+639% |
Q2 2025 |
Q1 2026 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q2 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
17.4K |
USD |
-9.28% |
Q2 2025 |
Q1 2026 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q2 2025 |
Q1 2026 |
| Deferred Tax Assets, Gross |
120K |
USD |
+81.4% |
Q2 2025 |
Q1 2026 |
| Deferred Tax Assets, Operating Loss Carryforwards |
103K |
USD |
+118% |
Q1 2025 |
FY 2025 |
| Deferred Federal Income Tax Expense (Benefit) |
0 |
USD |
|
Q2 2025 |
Q1 2026 |
| Additional Paid in Capital |
1.01M |
USD |
0% |
Q2 2025 |
Q1 2026 |
| Current State and Local Tax Expense (Benefit) |
3.28K |
USD |
|
Q2 2025 |
Q1 2026 |
| Current Federal Tax Expense (Benefit) |
10.6K |
USD |
+8.04% |
Q2 2025 |
Q1 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q1 2025 |
FY 2025 |
| Deferred State and Local Income Tax Expense (Benefit) |
0 |
USD |
|
Q2 2025 |
Q1 2026 |